back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-07 13:37 Tx date 2024-10-07 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,184.82
-694 vol $6.03 each |
7,776 | |
| Filed 2024-09-09 13:08 Tx date 2024-09-09 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,164
-694 vol $6.00 each |
8,470 | |
| Filed 2024-09-03 17:11 Tx date 2024-09-03 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-12,554.46
-2,082 vol $6.03 each |
9,164 | |
| Filed 2024-05-06 12:45 Tx date 2024-05-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,823.30
-694 vol $6.95 each |
11,246 | |
| Filed 2024-04-05 16:51 Tx date 2024-04-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-5,509.666
-694 vol $7.94 each |
11,940 | |
| Filed 2024-03-27 16:16 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$994,399
+110,000 vol $9.04 each |
1,722,500 | |
| Filed 2024-03-05 13:34 Tx date 2024-03-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-6,232.12
-694 vol $8.98 each |
12,634 | |
| Filed 2024-02-06 19:10 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,549
+1,718 vol $3.23 each |
15,740 | |
| Filed 2024-02-06 19:09 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,549.14
-1,718 vol $3.23 each |
1,685,782 | |
| Filed 2024-02-06 19:04 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-17,180
-1,718 vol $10.00 each |
14,022 | |
| Filed 2024-02-06 19:04 Tx date 2024-01-16 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,549
+1,718 vol $3.23 each |
||
| Filed 2024-02-06 18:59 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,615
+500 vol $3.23 each |
13,328 | |
| Filed 2024-02-06 18:56 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,615
-500 vol $3.23 each |
1,685,282 | |
| Filed 2024-02-06 18:53 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |
||
| Filed 2024-02-06 18:50 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-748,926.78
-72,782 vol $10.29 each |
13,328 | |
| Filed 2024-02-06 18:49 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$235,085
+72,782 vol $3.23 each |
86,110 | |
| Filed 2024-02-06 18:46 Tx date 2024-02-06 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-235,085.86
-72,782 vol $3.23 each |
1,612,500 | |
| Filed 2024-02-06 13:19 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-5,020
-500 vol $10.04 each |
13,328 | |
| Filed 2024-02-06 13:15 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |
13,828 | |
| Filed 2024-02-06 13:15 Tx date 2024-02-05 |
$EPI
ESSA Pharma Inc. |
Virsik, Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$1,615
+500 vol $3.23 each |